$0.3399
0.000.00%
Pre-Market: 7:13 AM EDT
Comments
Loading...
Mersana Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:MRSN | Benzinga
Mersana Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.170
Quarterly Revenue Estimate
$5.90M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$40.50M
Analyze the earnings history of Mersana Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSN | Mersana Therapeutics | -$0.16 | -$0.17 | — | — | $9.24M | $5.90M | — | — | 05/08/2025 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.16 | -$0.15 | -$0.11 | 26.67% | $10.70M | $7.71M | $16.36M | 112.20% | 03/03/2025 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.35 | -$0.17 | -$0.09 | 47.06% | $7.70M | $7.53M | $12.60M | 67.30% | 11/13/2024 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.47 | -$0.17 | -$0.20 | -17.65% | $10.65M | $9.13M | $2.29M | -74.88% | 08/13/2024 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.52 | -$0.18 | -$0.16 | 11.11% | $7.80M | $8.50M | $9.24M | 8.76% | 05/09/2024 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.44 | -$0.16 | -$0.16 | 0.00% | $14.69M | $14.77M | $10.70M | -27.55% | 02/28/2024 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.61 | -$0.36 | -$0.35 | 2.78% | $5.57M | $9.35M | $7.70M | -17.67% | 11/07/2023 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.55 | -$0.50 | -$0.47 | 6.00% | $4.28M | $8.45M | $10.65M | 26.08% | 08/08/2023 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.59 | -$0.44 | -$0.52 | -18.18% | $2.04M | $18.29M | $7.80M | -57.34% | 05/09/2023 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.68 | -$0.50 | -$0.44 | 12.00% | $11.00K | $15.28M | $14.69M | -3.87% | 02/28/2023 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.63 | -$0.09 | -$0.61 | -577.78% | $11.00K | $13.57M | $5.57M | -58.93% | 11/07/2022 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.59 | -$0.52 | -$0.55 | -5.77% | $11.00K | $2.18M | $4.28M | 96.51% | 08/08/2022 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.50 | -$0.32 | -$0.59 | -84.38% | $11.00K | — | $2.04M | — | 05/09/2022 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.42 | -$0.67 | -$0.68 | -1.49% | $10.00K | — | $11.00K | — | 02/28/2022 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.33 | -$0.58 | -$0.63 | -8.62% | $11.00K | $100.00K | $11.00K | -89.00% | 11/09/2021 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.33 | -$0.50 | -$0.59 | -18.00% | $796.00K | $140.00K | $11.00K | -92.14% | 08/06/2021 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.35 | -$0.39 | -$0.50 | -28.21% | $11.00K | — | $11.00K | — | 05/10/2021 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.34 | -$0.32 | -$0.42 | -31.25% | $42.00K | $170.00K | $10.00K | -94.12% | 02/26/2021 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.35 | -$0.30 | -$0.33 | -10.00% | $844.00K | — | $11.00K | — | 11/09/2020 | Get Alert |
| MRSN | Mersana Therapeutics | -$0.36 | -$0.30 | -$0.33 | -10.00% | $202.00K | $300.00K | $796.00K | 165.33% | 08/07/2020 | Get Alert |
| MRSN | Mersana Therapeutics | $0.70 | -$0.37 | -$0.35 | 5.41% | $41.03M | $390.00K | $11.00K | -97.18% | 05/08/2020 | Get Alert |
Mersana Therapeutics (MRSN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $-0.11 | $-0.15 | 26.7 % |
| Q3 | 2024-11-13 | $-0.09 | $-0.17 | 47.1 % |
| Q2 | 2024-08-13 | $-0.20 | $-0.17 | -17.6 % |
| Q1 | 2024-05-09 | $-0.16 | $-0.18 | 11.1 % |
Mersana Therapeutics (MRSN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $16.36M | $7.71M | 112.2 % |
| Q3 | 2024-11-13 | $12.60M | $7.53M | 67.3 % |
| Q2 | 2024-08-13 | $2.29M | $9.13M | -74.9 % |
| Q1 | 2024-05-09 | $9.24M | $8.50M | 8.76 % |
FAQ
When is Mersana Therapeutics (NASDAQ:MRSN) reporting earnings?
Mersana Therapeutics (MRSN) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Mersana Therapeutics (NASDAQ:MRSN)?
The Actual EPS was $-0.11, which beat the estimate of $-0.15.
What were Mersana Therapeutics’s (NASDAQ:MRSN) revenues?
The Actual Revenue was $16.4M, which beat the estimate of $7.7M.
Browse earnings estimates, EPS, and revenue on all stocks.